Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome

View ORCID ProfileR. Alan Harris, Kellie J. Archer, View ORCID ProfileMark O. Goodarzi, Timothy P. York, View ORCID ProfileJeffrey Rogers, View ORCID ProfileAndrea Dunaif, Jan McAllister, View ORCID ProfileJerome F Strauss III
doi: https://doi.org/10.1101/2022.05.10.22274861
R. Alan Harris
1Human Genome Sequencing Center and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Alan Harris
Kellie J. Archer
2Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH 43210 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark O. Goodarzi
3Division of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark O. Goodarzi
Timothy P. York
4Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298 USA
5Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23298 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Rogers
1Human Genome Sequencing Center and Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey Rogers
Andrea Dunaif
6Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Dunaif
Jan McAllister
7Department of Pathology, Penn State Hershey College of Medicine, Hershey, PA 17033 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerome F Strauss III
5Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23298 USA
8Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, 19104 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jerome F Strauss III
  • For correspondence: jerome.strauss{at}pennmedicine.upenn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenemia of ovarian theca cell origin. Here we report the significant association of 15 single nucleotide polymorphisms (SNPs), identified by whole exome sequencing (WES). DNA was isolated from well-characterized theca cell preparations from women of European ancestry with PCOS (N=9) and elevated androgen production in vitro and from normal ovulatory women (N=7). Of the SNPs, 10 are located within 150 kb on chromosome 12q13.2. This region contains three plausible PCOS candidate genes (ERBB3/PA2G4/RAB5B), two of which (ERBB3 and RAB5B) have been identified in GWAS of PCOS. None of the SNPs individually had a significant association with PCOS or in vivo androgen levels when evaluated in an independent cohort (n=318) of families with one or more daughters with PCOS, but a haplotype consisting of the minor alleles of three of the SNPS (rs773121, rs773123 and rs812826) was found preferentially in women with PCOS and elevated androgen levels (p=0.0583). Moreover, the three minor alleles in this haplotype were significantly associated with anti-Mullerian Hormone (AMH) levels, a marker of follicular reserve and follicular maturation. Two of the three SNP minor alleles are predicted to have significant functional consequences (rs773123 a missense SNP in ERBB3, and rs812826, a SNP in the PA2G4 promoter). Notably, PA2G4 encodes a protein that interacts with the ERBB3 cytoplasmic domain, which is also the domain where the missense variant resides. These findings provide support for the contribution and probable functional significance of loci on chromosome 12q13.2 to the pathophysiology underlying PCOS.

Author Summary Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of reproductive age. We identified 15 single nucleotide polymorphisms (SNPs) associated with androgen production in theca cells from normal ovulatory women and women with PCOS. Of these SNPs, 10 are within a 150 kbp region of chromosome 12 including 9 that form a haplotype. This region contains three PCOS candidate genes (ERBB3/PA2G4/RAB5B). These SNPs were further examined in an independent cohort of families with one or more daughters with PCOS. A haplotype consisting of the minor alleles of three of the SNPS was found preferentially in women with PCOS. Furthermore, the three minor alleles in this haplotype were significantly associated with anti-Mullerian Hormone (AMH) levels, a marker of follicular reserve and maturation. Two SNPs in the chromosome 12 haplotype were likely to have functional consequences based on genomic context, suggesting that they affect ERBB3 and PA2G4 interactions or PA2G4 expression.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded in part by the National Institutes of Health grants R01HD083323 (to J.M.M and J.F.S.), R01HD100812 (to A.D.), and R01HD108744 (to A.D.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Review Boards of Northwestern University Feinberg School of Medicine, Penn State Health Milton S. Hershey Medical Center, and Brigham and Women's Hospital. Written informed consent was obtained from all subjects prior to the study.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • rharris1{at}bcm.edu, archer.43{at}osu.edu, mark.goodarzi{at}cshs.org, tpyork{at}vcu.edu, jr13{at}bcm.edu, andrea.dunaif{at}mssm.edu, jxm63{at}psu.edu, jerome.strauss{at}pennmedicine.upenn.edu

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome
R. Alan Harris, Kellie J. Archer, Mark O. Goodarzi, Timothy P. York, Jeffrey Rogers, Andrea Dunaif, Jan McAllister, Jerome F Strauss III
medRxiv 2022.05.10.22274861; doi: https://doi.org/10.1101/2022.05.10.22274861
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome
R. Alan Harris, Kellie J. Archer, Mark O. Goodarzi, Timothy P. York, Jeffrey Rogers, Andrea Dunaif, Jan McAllister, Jerome F Strauss III
medRxiv 2022.05.10.22274861; doi: https://doi.org/10.1101/2022.05.10.22274861

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)